CRISPR
VedaBio raises $40 million to develop CRISPR-based diagnostics
Anika Sharma
A groundbreaking venture, VedaBio, has emerged from stealth mode with an ambitious vision of advancing CRISPR technology to new heights. ...
FDA Sets December Deadline for Vertex and CRISPR’s Sickle Cell Therapy
SG Tylor
The US Food and Drug Administration (FDA) has initiated a priority review of exagamglogene autotemcel (exa-cel), a therapy developed by ...
